Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Understanding Drivers of Employment Changes in a Multiple Sclerosis Population.
Pediatric Urinary Retention in the Emergency Department: A Concerning Symptom with Etiology Outside the Bladder.
Preventing brain atrophy should be the gold standard of effective therapy in multiple sclerosis (after the first year of treatment): Commentary.
Inflammatory bowel disease: An archetype disorder of outer environment sensor systems.
Immunopathological patterns from EAE and Theiler's virus infection: Is multiple sclerosis a homogenous 1-stage or heterogenous 2-stage disease?
Vitamin d and multiple sclerosis.
Genetic inactivation of mitochondria-targeted redox enzyme p66ShcA preserves neuronal viability and mitochondrial integrity in response to oxidative challenges.
Prolactin in multiple sclerosis.
Blood-Brain Barrier Disruption is More Severe in Neuromyelitis Optica than in Multiple Sclerosis and Correlates with Clinical Disability.
Kinetics of Proinflammatory Monocytes in a Model of Multiple Sclerosis and Its Perturbation by Laquinimod.
Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: A double blind randomized clinical trial.
Interferon-β1a modulates glutamate neurotransmission in the CNS through CaMKII and GluN2A-containing NMDA receptors.
Optical Coherence Tomography for the Radiologist.
Neural stem cell diversity and proteomics.
[Anti-MOG antibody in different types of immune-mediated optic neuritis].
Experimental Autoimmune Encephalomyelitis in Mice.
Impaired Object Handling during Bimanual Task Performance in Multiple Sclerosis.
Acute Transverse Myelitis Associated With Human Parvovirus B19 Infection.
Glycopeptide-based antibody detection in multiple sclerosis by surface plasmon resonance.
Stiffness as a presenting symptom of an odd clinical condition caused by multiple sclerosis and myotonia congenita.
2010 McDonald criteria for diagnosing pediatric multiple sclerosis.
Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex®) for Spasticity in Multiple Sclerosis.
Color blindness among multiple sclerosis patients in Isfahan.
High spatial and angular resolution diffusion-weighted imaging reveals forniceal damage related to memory impairment.
Treatment patterns in multiple sclerosis: administrative claims analysis over 10 years.
Pages
« first
‹ previous
…
300
301
302
303
304
305
306
307
308
…
next ›
last »